Mo Li
Title
Cited by
Cited by
Year
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
K Suzuki, Y Tsunekawa, R Hernandez-Benitez, J Wu, J Zhu, EJ Kim, ...
Nature 540 (7631), 144-149, 2016
5992016
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging
W Zhang, J Li, K Suzuki, J Qu, P Wang, J Zhou, X Liu, R Ren, X Xu, ...
Science 348 (6239), 1160-1163, 2015
3102015
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
GH Liu, J Qu, K Suzuki, E Nivet, M Li, N Montserrat, F Yi, X Xu, S Ruiz, ...
Nature 491 (7425), 603-607, 2012
3022012
In vivo amelioration of age-associated hallmarks by partial reprogramming
A Ocampo, P Reddy, P Martinez-Redondo, A Platero-Luengo, F Hatanaka, ...
Cell 167 (7), 1719-1733. e12, 2016
3012016
Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
HK Liao, Y Gu, A Diaz, J Marlett, Y Takahashi, M Li, K Suzuki, R Xu, ...
Nature communications 6 (1), 1-10, 2015
2642015
Targeted Gene Correction of Laminopathy-Associated LMNA Mutations in Patient-Specific iPSCs
GH Liu, K Suzuki, J Qu, I Sancho-Martinez, F Yi, M Li, S Kumar, E Nivet, ...
Cell stem cell 8 (6), 688-694, 2011
2322011
An alternative pluripotent state confers interspecies chimaeric competency
J Wu, D Okamura, M Li, K Suzuki, C Luo, L Ma, Y He, Z Li, C Benner, ...
Nature 521 (7552), 316-321, 2015
1702015
Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones
K Suzuki, C Yu, J Qu, M Li, X Yao, T Yuan, A Goebl, S Tang, R Ren, ...
Cell stem cell 15 (1), 31-36, 2014
1672014
Conversion of human fibroblasts to angioblast-like progenitor cells
L Kurian, I Sancho-Martinez, E Nivet, A Aguirre, K Moon, C Pendaries, ...
Nature methods 10 (1), 77, 2013
1522013
Endosomal escape and delivery of CRISPR/Cas9 genome editing machinery enabled by nanoscale zeolitic imidazolate framework
SK Alsaiari, S Patil, M Alyami, KO Alamoudi, FA Aleisa, JS Merzaban, M Li, ...
Journal of the American Chemical Society 140 (1), 143-146, 2018
1392018
A cut above the rest: targeted genome editing technologies in human pluripotent stem cells
M Li, K Suzuki, NY Kim, GH Liu, JCI Belmonte
Journal of Biological Chemistry 289 (8), 4594-4599, 2014
1362014
Autophagic control of cell ‘stemness’
H Pan, N Cai, M Li, GH Liu, JCI Belmonte
EMBO molecular medicine 5 (3), 327-331, 2013
1192013
Navigating the epigenetic landscape of pluripotent stem cells
M Li, GH Liu, JCI Belmonte
Nature reviews Molecular cell biology 13 (8), 524-535, 2012
1092012
Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs
GH Liu, K Suzuki, M Li, J Qu, N Montserrat, C Tarantino, Y Gu, F Yi, X Xu, ...
Nature communications 5 (1), 1-17, 2014
1002014
3D culture supports long-term expansion of mouse and human nephrogenic progenitors
Z Li, T Araoka, J Wu, HK Liao, M Li, M Lazo, B Zhou, Y Sui, MZ Wu, ...
Cell stem cell 19 (4), 516-529, 2016
972016
Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc
A Giorgetti, MCN Marchetto, M Li, D Yu, R Fazzina, Y Mu, A Adamo, ...
Proceedings of the National Academy of Sciences 109 (31), 12556-12561, 2012
792012
Ground rules of the pluripotency gene regulatory network
M Li, JCI Belmonte
Nature Reviews Genetics 18 (3), 180, 2017
782017
Efficient correction of hemoglobinopathy-causing mutations by homologous recombination in integration-free patient iPSCs
M Li, K Suzuki, J Qu, P Saini, I Dubova, F Yi, J Lee, I Sancho-Martinez, ...
Cell research 21 (12), 1740-1744, 2011
662011
Organoids-Preclinical Models of Human Disease.Reply.
JCIB M Li
The New England journal of medicine 380 (20), 1981, 2019
65*2019
Organoids—Preclinical Models of Human Disease
M Li, JC Izpisua Belmonte
New England Journal of Medicine 380 (6), 569-579, 2019
642019
The system can't perform the operation now. Try again later.
Articles 1–20